Hikal Ltd
Kuldeep Jain, is the Chief Finance Officer. He has over 30 years of experience in financial operations and strategic planning and brings a wealth of experience in accounting, financial planning, analysis, taxation and audits. He has been with Hikal for the past 23 years. Mr. Jain has been responsible for the planning, implementation and management of all the financial activities of the Company, including business planning, budgeting, forecasting, investment analysis and analysing the Company's financial strengths and weaknesses. He has partnered across the business and led various projects such as ERP implementation, GST transformation, new MIS and costing systems and digital finance initiatives. Kuldeep is a qualified Chartered Accountant and Member of the Institute of Chartered Accountants of India, New Delhi.
This person is not in any offices
Hikal Ltd
1 followers
Hikal Limited is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharmaceutical ingredients (APIs) and contract research activities. The Company offers pharmaceuticals and agrochemicals. Its segments include Crop Protection and Pharmaceuticals. It offers agrochemicals, including active ingredients, such as Ammonium dithiocarbamate, Amitrole Tech, Diuron Tech, Ethion Tech, Imazalil Tech, Isoproturon Tech, Meta chloro Aniline (MCA), Quinalphos Tech and Temephos Tech, and intermediates and specialty chemicals, such as Phenyl-2-(phenylthio)-phenyl carbamate, 4-(Benzyloxy) Aniline Hydrochloride, N-Benzylpiperidine-4-carboxaldehyde, 3-Chloroaniline and 4 Aminobenzylamine. Its APIs include Gabapentin, Pregabalin, Levetiracetam, Quetiapine Fumarate, Memantine Hydrochloride, Venlafaxine Hydrochloride and Donepezil Hydrochloride. The Company operates in geographical areas, including India, Europe, the United States, Canada and South East Asia.